Wells raised its price target on Celanese to $66 from $45, pointing to expected sequential earnings improvement driven by cost savings and reduced maintenance activity. The stock has fallen about 70% ...

Investing.com -- Truist Securities launched coverage on four diabetes technology companies, saying there is a long-term growth potential for continuous glucose monitors (CGM) and insulin pumps amid ...